LATEST PSYCHEDELICS STOCKS NEWS


Notice: Function WP_Object_Cache::add was called incorrectly. Cache key must not be an empty string. Please see Debugging in WordPress for more information. (This message was added in version 6.1.0.) in /var/www/vhosts/shroominvestor.com/httpdocs/web/wp/wp-includes/functions.php on line 6031
1 views8 min read

Cybin Goes Public on NEO Exchange

Cybin
NEO is excited to announce that Cybin Inc. ("Cybin" or the "Company"), a leading Toronto-based biotech and life sciences company focused on psychedelic pharmaceutical therapies, has made its debut on the global public markets today. Cybin is now trading on the NEO Exchange under the symbol NEO:CYBN.This press release features multimedia. ... Read More...
M & A1 views4 min read

Red Light Holland to Acquire Wholesale Distribution Company in the Netherlands Providing Access to over 1,000 Retail Outlets in Multiple EU Countries

Red Light Holland
Toronto, Ontario--(Newsfile Corp. - November 10, 2020) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) ("Red Light Holland" or the "Company"), is pleased to announce it has entered into a non-binding letter of intent to acquire SR Wholesale B.V. ("SR Wholesale"), one of the Netherlands' premiere distributors for quality Truf... Read More...
583 views3 min read

Hollister Biosciences Inc. Launches Direct to Consumer Cannabis Delivery Platform, Dreamy Delivery

Hollister Biosciences
VANCOUVER, BC, Nov. 10, 2020 - Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the "Company", "Hollister Cannabis Co." or "Hollister") a diversified cannabis branding company with products in over 280 dispensaries throughout California, and over 80 dispensaries throughout Arizona, is pleased to announce the launch of... Read More...
1 views6 min read

Pre-IND Discussion with U.S. FDA Helps BetterLife Set Up AP-003 Clinical Trials in Australia

BetterLife Pharma
VANCOUVER, Nov. 10, 2020 -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company focused on development and commercialization of interferon based treatments, today announced a clinical and regulatory update for its AP-003 COVID-19 clinical trials following discussions wi... Read More...
210 views4 min read

Clean Power Capital Corp.: Hydrogen Fuel’s Future Is Brighter Under a Joe Biden USA Presidency

Clean Power Capital
VANCOUVER, British Columbia, Nov. 10, 2020 -- Clean Power Capital Corp. (CSE: MOVE)(FWB: 2K6)(OTC: QILFF) (“Clean Power” or the “Company” or "MOVE"). The Company’s 90 percent owned subsidiary PowerTap Hydrogen Fueling Corp. (“PowerTap”) is pleased to provide commentary on the impact of the election of Joe Biden as the next President of th... Read More...
134 views3 min read

Empower Clinics Announces Closing of $1.228 Million Private Placement Financing and Insider Subscription

Empower Clinics
VANCOUVER, BC / ACCESSWIRE / November 9, 2020 / Empower Clinics Inc. ("Empower" or the "Company") (CSE:CBDT), is pleased to announce that it has closed its previously announced private placement of units of the Company (the "Units"), which included the exercise of an over-allotment option, pursuant to which the Company issued 24,567,131 U... Read More...
1 views4 min read

IntelGenx Announces Publication of a Study Evaluating Montelukast’s Effect on Neurological Aging

IntelGenx Technologies
- Data Suggest Montelukast May Inhibit Mental Decline, Higher Doses Optimal for Clinical Trials Assessing Impact on Neurological Disease -SAINT LAURENT, Quebec, Nov. 09, 2020 -- IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that the peer-reviewed journal, International Journal of Clinical Pharmacy,... Read More...
1 views3 min read

Silo Pharma, Inc. Launches Scientific Advisory Board with Appointment of Dr. Matthew Johnson of John Hopkins University

Silo Pharma
Industry Recognized Expert in Psychedelics and Related Safety GuidelinesNEW YORK, Nov. 09, 2020 -- Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced it has formed a Scientific Advisory Board for evaluating opportunities to advance strategies r... Read More...
1 views3 min read

COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care

COMPASS Pathways plc
London, UK - 9 November 2020COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has joined the Psychiatry Consortium, an international collaboration to accelerate drug discovery and development in areas of urgent, unmet medical need.The P... Read More...
1 views3 min read

IntelGenx to Report Third Quarter 2020 Financial Results on November 12, 2020 – Conference Call to Follow

IntelGenx Technologies
SAINT LAURENT, Quebec, Nov. 05, 2020 -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that it will release its third quarter 2020 financial results after market close on Thursday, November 12, 2020.An accompanying conference call will be hosted by Dr. Horst G. Zerbe, Chief Executive Officer, and Mr. Andre Godin, P... Read More...
M & A71 views4 min read

Nova Mentis Life Science Acquisition Target, Pilz Bioscience Corp, Signs Psilocybin Manufacturing Agreement

Novamind
VANCOUVER, BC, Nov. 5, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that its pending acquisition target, Pilz Bioscience Corp. ("Pilz"), has entered into a psilocybin manufacturing agreement with a U.S. based pharmaceutical company with over 800 employees. Pilz will have comp... Read More...
224 views4 min read

Field Trip Health Ltd. Prepares to Enter Oregon Market following the Passage of Measure 109 in Oregon, Creating the First Legal Market for Psilocybin Services

Field Trip, which has been legally cultivating a variety of psilocybin-producing mushrooms in Jamaica, and is rolling out Field Trip Health centers for the delivery of psychedelic therapies, is positioned be a leader in the emerging psychedelic renaissanceTORONTO, Nov. 05, 2020 -- Field Trip Health Ltd. (CSE: FTRP) ("Field Trip"), one of ... Read More...
1 views2 min read

COMPASS Pathways plc to announce third quarter 2020 financial results on 12 November 2020

COMPASS Pathways plc
London, UK, Nov. 05, 2020 --COMPASS Pathways plc to announce third quarter 2020 financial resultson 12 November 2020London, UK - 5 November 2020COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release finan... Read More...
84 views1 min read

Organic Flower Announces Name Change

Clean Power Capital
VANCOUVER, British Columbia, Nov. 05, 2020 -- Organic Flower Investments Group Inc. (CSE: SOW)(FWB: 2K6)(OTC: QILFF) (“Organic Flower” or the “Company” or "SOW") announces that pursuant to the approval by its board of directors, it will change its name to Clean Power Capital Corp. The Company will also concurrently change its ticker symbo... Read More...
932 views6 min read

Green Spoon Sales to Represent Koios™ and Fit Soda™ Among Leading Natural Food and Beverage Products in up to 20 U.S. States

Koios Beverage
Recent postings made by Green Spoon on its Instagram account showing in-store initiatives (@greenspoonsales)Readers using news aggregation services may be unable to view the media above. Please access the Investor Relations section of the Company’s website for a version of this press release containing all published media.Readers using ne... Read More...
1 views4 min read

BetterLife Pharma Signs eTMF Partner to Help Accelerate AP-003 Clinical Trial Operations

BetterLife Pharma
VANCOUVER, Nov. 04, 2020 -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company that is beginning clinical trials of AP-003, its COVID-19 inhalation therapeutic, announced today that it has selected Florence Healthcare to provide its electronic Trial Master File (‘eTMF’... Read More...
89 views6 min read

Koios’ Fit Soda™ to be Carried in Over 100 HEB Supermarket Locations Throughout Texas

Koios Beverage
“Sparkling Citrus” Fit Soda™ in the new four-pack format to be carried at more than 100 HEB supermarkets in TexasReaders using news aggregation services may be unable to view the media above. Please access the Investor Relations section of the Company’s website for a version of this press release containing all published media.Readers usi... Read More...
M & A832 views4 min read

Nova Mentis Life Science Signs Amalgamation Agreement to Acquire 100% of Pilz BioScience Corp.

Novamind
VANCOUVER, BC, Nov. 2, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that, further to its news release dated October 9, 2020, it has entered into a definitive amalgamation agreement, (the "Definitive Agreement") with Pilz Bioscience Corp. ("Pilz") and 1271642 B.C. Ltd. ("Nova ... Read More...
1036 views4 min read

Hydrogen Long Haul Trucks are Coming

Clean Power Capital
PowerTap planning to build a hydrogen station network that is needed to fuel hydrogen vehiclesVANCOUVER, British Columbia, Nov. 02, 2020 -- Organic Flower Investments Group Inc. (CSE: SOW)(FWB: 2K6)(OTC: QILFF) (“Organic Flower” or the “Company” or "SOW"). The Company’s 90 percent owned subsidiary PowerTap Hydrogen Fueling Corp. (“PowerTa... Read More...
504 views5 min read

MindMed Announces the Completion of Phase 1 Study Measuring Dosing Effects of LSD

Mind Medicine (MindMed)
Data to Support MindMed's Project Lucy in Preparing Phase 2b Trial for Anxiety DisordersNEW YORK, Nov. 2, 2020 -- MindMed (NEO: MMED, OTCQB: MMEDF), the leading psychedelic medicine biotech company in partnership with University Hospital Basel's Liechti Lab announces the completion and publication of a Phase 1 study on the acute dose depe... Read More...
1340 views5 min read

Empower Clinics Growth Strategy Accelerates With Recent Major Initiatives. Updates Status And Outlook Into 2021

Empower Clinics
VANCOUVER BC / ACCESSWIRE / November 2, 2020 / EMPOWER CLINICS INC. Empower Clinics (CBDT:CSE)(EPWCF:OTC)(8EC:FRA) (the "Company" or "Empower"), an integrated healthcare company serving a database of 165,000 patients through clinics in the southwest United States, a telemedicine platform and medical diagnostics laboratory, is pleased to p... Read More...
419 views4 min read

Captiva Verde Comprehensive Update

Captiva Verde Land
Coquitlam, British Columbia--(Newsfile Corp. - November 1, 2020) - Captiva Verde Land Corp. (CSE: PWR) (OTC: CPIVF) (the "Company"), is pleased to report an update on all of our major operating business segments plus our recommendation of a financial newsletter written by an award winning portfolio manager.Financial Newsletter - Grit Capi... Read More...
723 views4 min read

Nutritional High Announces Completion of the Conversion of the 10% Senior Unsecured Convertible Debentures

Nutritional High International
Toronto, Ontario--(Newsfile Corp. - October 30, 2020) -  Nutritional High International Inc. (CSE: EAT) (OTC Pink: SPLIF) ("Nutritional High" or the "Company") is pleased to announce that the Company has completed the proposed conversion of the 10% senior unsecured convertible Debentures (the "10% Debentures") described in the management ... Read More...
1 views3 min read

Aion Therapeutic Amends Convertible Debentures

Aion Therapeutic
Toronto, Ontario--(Newsfile Corp. - October 30, 2020) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that the Company has entered into a convertible debenture extension and amendment agreement (the "Amending Agreement") dated October 29, 2020 with Quinsam Capital Corporation (the "Lender"). The A... Read More...
558 views4 min read

MindMed Closes Upsized Financing of CAD $28.75m With Strong Institutional Demand for Psychedelic Medicines

Mind Medicine (MindMed)
Post-Financing Cash Reserves of CAD $50.1m (USD $37.8m) to Enable Continued Advancement of Diverse and Growing Clinical Trial Pipeline of PsychedelicsNOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Oct. 30, 2020 -- Mind Medicine (MindMed) Inc. (NEO: MMED, OTCQB: MMEDF) ("MindMed" o... Read More...





Make smarter investment strategies
with in-depth news reports

Join our subscribers!